Why Is Altimmune (ALT) Stock Up 14% Today?

Altimmune stock is rising higher on Monday as ALT investors react to positive news from rival weight loss drugmaker Zealand Pharma.

Wall Street Analysts Think Altimmune, Inc. (ALT) Could Surge 352%: Read This Before Placing a Bet

Altimmune Inc. (ALT stock) - Bad Drug Trial News Weighs it Down - The Coin Republic

Altimmune shares slide after Kerrisdale Capital takes short position

Altimmune: Don't Buy The GLP-1 Move-Up (NASDAQ:ALT)

TEVA Stock Pops 4% as Teva Receives FDA Approval

Investing Insights & Market Analysis [Issue #23: Week 50, December 2023]

Trial success is rocketing this NASH stock higher and sinking these peers MDGL;VKTX;ICPT;ETNB;ALT

Altimmune (ALT) to Report Q4 Earnings: What's in the Cards? - February 20, 2024

Altimmune Stock News (ALT)

Altimmune Stock Price Today, ALT Stock Price Chart

Where M&A could be heading in the obesity drug space

Altimmune Stock Price Today, ALT Stock Price Chart